Chronic mucocutaneous candidiasis: a spectrum of genetic disorders

Ahonen P., Myllärniemi S., Sipilä I., and Perheentupa J. 1990. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322(26):1829–1836.

Akira S., Uematsu S., and Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell. 124(4):783–801.

Babula O., Lazdane G., Kroica J., Ledger W.J., and Witkin S.S. 2003. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin. Infect. Dis. 37(5):733–737.

Betterle C., Greggio N.A., and Volpato M. 1998. Clinical review 93: Autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 83(4):1049–1055.

Björses P., Aaltonen J., Horelli-Kuitunen N., Yaspo M.L., and Peltonen L. 1998. Gene defect behind APECED: A new clue to autoimmunity. Hum. Mol. Genet. 7(10):1547–1553.

Boisson B., Wang C., Pedergnana V., Wu L., Cypowyj S., Rybojad M., Belkadi A., Picard C., Abel L., Fieschi C., Puel A., Li X., and Casanova J.L. 2013. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 39(4):676–686.

Boisson-Dupuis S., Kong X.-F., Okada S., Cypowyj S., Puel A., Abel L., and Casanova J.L. 2012. Inborn errors of human STAT1: Allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24(4):364–378.

Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G.F., Lucarelli P., Pellecchia M., Eisenbarth G.S., Comings D., and Mustelin T. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36(4):337–338.

Brown G.D. and Gordon S. 2001. Immune recognition: A new receptor for β-glucans. Nature. 413(6851):36–37.

Chitnis A.S., Magill S.S., Edwards J.R., Chiller T.M., Fridkin S.K., and Lessa F.C. 2012. Trends in Candida central line-associated bloodstream infections among NICUs, 1999–2009. Pediatrics. 130(1):e46–e52.

Choi E.H., Foster C.B., Taylor J.G., Erichsen H.C., Chen R.A., Walsh T.J., Anttila V.J., Ruutu T., Palotie A., and Chanock S.J. 2003. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J. Infect. Dis. 187(7):1153–1156.

Das I., Nightingale P., Patel M., and Jumaa P. 2011. Epidemiology, clinical characteristics, and outcome of candidemia: Experience in a tertiary referral center in the UK. Int. J. Infect. Dis. 15(11):e759–e763.

de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., Feinberg J., von Bernuth H., Samarina A., Jannière L., Fieschi C., Stéphan J.L., Boileau C., Lyonnet S., Jondeau G., Cormier-Daire V., Le Merrer M., Hoarau C., Lebranchu Y., Lortholary O., Chandesris M.O., Tron F., Gambineri E., Bianchi L., Rodriguez-Gallego C., Zitnik S.E., Vasconcelos J., Guedes M., Vitor A.B., Marodi L., Chapel H., Reid B., Roifman C., Nadal D., Reichenbach J., Caragol I., Garty B.Z., Dogu F., Camcioglu Y., Gülle S., Sanal O., Fischer A., Abel L., Stockinger B., Picard C., and Casanova J.L. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells. J. Exp. Med. 205(7):1543–1550.

Donlan R.M. and Costerton J.W. 2002. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2):167–193.

Engelhardt K.R., McGhee S., Winkler S., Sassi A., Woellner C., Lopez-Herrera G., Chen A., Kim H.S., Lloret M.G., Schulze I., Ehl S., Thiel J., Pfeifer D., Veelken H., Niehues T., Siepermann K., Weinspach S., Reisli I., Keles S., Genel F., Kutukculer N., Camcioğlu Y., Somer A., Karakoc-Aydiner E., Barlan I., Gennery A., Metin A., Degerliyurt A., Pietrogrande M.C., Yeganeh M., Baz Z., Al-Tamemi S., Klein C., Puck J.M., Holland S.M., McCabe E.R., Grimbacher B., and Chatila T.A. 2009. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124(6):1289–1302.e4.

Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C., Jacobs L., Jansen T., Verheijen K., Masthoff L., Morré S.A., Vriend G., Williams D.L., Perfect J.R., Joosten L.A., Wijmenga C., van der Meer J.W., Adema G.J., Kullberg B.J., Brown G.D., and Netea M.G. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361(18):1760–1767.

Giraldo P.C., Babula O., Gonçalves A.K.S., Linhares I.M., Amaral R.L., Ledger W.J., and Witkin S.S. 2007. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet. Gynecol. 109(5):1123–1128.

Gjörloff-Wingren A., Saxena M., Williams S., Hammi D., and Mustelin T. 1999. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29(12):3845–3854.

Glocker E.-O., Hennigs A., Nabavi M., Schäffer A.A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., Jamal S., Manguiat A., Rezaei N., Amirzargar A.A., Plebani A., Hannesschläger N., Gross O., Ruland J., and Grimbacher B. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361(18):1727–1735.

Gregorieff A., Cloutier J.F., and Veillette A. 1998. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk). J. Biol. Chem. 273(21):13217–13222.

Gross O., Gewies A., Finger K., Schäfer M., Sparwasser T., Peschel C., Förster I., and Ruland J. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 442(7103):651–656.

Hernández-Santos N. and Gaffen S.L. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe. 11(5):425–435.

Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schäffer A.A., Puck J.M., and Grimbacher B. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357(16):1608–1619.

Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126(6):1121–1133.

Iwakura Y., Ishigame H., Saijo S., and Nakae S. 2011. Functional specialization of interleukin-17 family members. Immunity. 34(2):149–62.

Johnson M.D., Plantinga T.S., van de Vosse E., Velez Edwards D.R., Smith P.B., Alexander B.D., Yang J.C., Kremer D., Laird G.M., Oosting M., Joosten L.A., van der Meer J.W., van Dissel J.T., Walsh T.J., Perfect J.R., Kullberg B.J., Scott W.K., and Netea M.G. 2012. Cytokine gene polymorphisms and the outcome of invasive candidiasis: A prospective cohort study. Clin. Infect. Dis. 54(4):502–510.

Jouault T., Ibata-Ombetta S., Takeuchi O., Trinel P., Sacchetti P., Lefebvre P., Akira S., and Poulain D. 2003. Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 188(1):165–172.

Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., and Tuomilehto J. 2000. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 23(10):1516–1526.

Kirkpatrick C.H. 1994. Chronic mucocutaneous candidiasis. J. Am. Acad. Dermatol. 31(3):S14–S17.

Kisand K., Bøe Wolff A.S., Podkrajšek K.T., Tserel L., Link M., Kisand K.V., Ersvaer E., Perheentupa J., Erichsen M.M., Bratanic N., Meloni A., Cetani F., Perniola R., Ergun-Longmire B., Maclaren N., Krohn K.J., Pura M., Schalke B., Ströbel P., Leite M.I., Battelino T., Husebye E.S., Peterson P., Willcox N., and Meager A. 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207(2):299–308.

Lanternier F., Pathan S., Vincent Q., Liu L., Cypowij S., Prando C., Migaud M., Taibi L., Ammar-Khodja A., Stambouli O.B., Guellil B., Jacobs F., Goffard J.-C., Shepers K., del Marmol V., Bachelez H., Michel L., Lefranc G., Fraitag S., Bougnoux M.-E., and Boudia A. 2012. Human invasive dermatophytic disease is caused by inborn errors of CARD9. J. Clin. Immunol. 32:1–379.

Lev-Sagie A., Prus D., Linhares I.M., Lavy Y., Ledger W.J., and Witkin S.S. 2009. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 200(3):303.e1–303.e6.

Lévy R., Okada S., Béziat V., Moriya K., Liu C., Chai L.Y.A., Migaud M., Hauck F., Al Ali A., Cyrus C., Vatte C., Patiroglu T., Unal E., Ferneiny M., Hyakuna N., Nepesov S., Oleastro M., Ikinciogullari A., Dogu F., Asano T., Ohara O., Yun L., Della Mina E., Bronnimann D., Itan Y., Gothe F., Bustamante J., Boisson-Dupuis S., Tahuil N., Aytekin C., Salhi A., Al Muhsen S., Kobayashi M., Toubiana J., Abel L., Li X., Camcioglu Y., Celmeli F., Klein C., AlKhater S.A., Casanova J.L., and Puel A. 2016. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc. Natl. Acad. Sci. USA. 113(51):E8277–E8285.

Ling Y., Cypowyj S., Aytekin C., Galicchio M., Camcioglu Y., Nepesov S., Ikinciogullari A., Dogu F., Belkadi A., Levy R., Migaud M., Boisson B., Bolze A., Itan Y., Goudin N., Cottineau J., Picard C., Abel L., Bustamante J., Casanova J.L., and Puel A. 2015. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J. Exp. Med. 212(5):619–631.

Liu L., Okada S., Kong X.-F., Kreins A.Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., Masson C., Toth B., Flatot J., Migaud M., Chrabieh M., Kochetkov T., Bolze A., Borghesi A., Toulon A., Hiller J., Eyerich S., Eyerich K., Gulácsy V., Chernyshova L., Chernyshov V., Bondarenko A., Grimaldo R.M., Blancas-Galicia L., Beas I.M., Roesler J., Magdorf K., Engelhard D., Thumerelle C., Burgel P.R., Hoernes M., Drexel B., Seger R., Kusuma T., Jansson A.F., Sawalle-Belohradsky J., Belohradsky B., Jouanguy E., Bustamante J., Bué M., Karin N., Wildbaum G., Bodemer C., Lortholary O., Fischer A., Blanche S., Al-Muhsen S., Reichenbach J., Kobayashi M., Rosales F.E., Lozano C.T., Kilic S.S., Oleastro M., Etzioni A., Traidl-Hoffmann C., Renner E.D., Abel L., Picard C., Maródi L., Boisson-Dupuis S., Puel A., and Casanova J.L. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208(8):1635–1648.

Maródi L., Cypowyj S., Tóth B., Chernyshova L., Puel A., and Casanova J.L. 2012. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J. Allergy Clin. Immunol. 130(5):1019–1027.

McGeachy M.J. and McSorley S.J. 2012. Microbial-induced Th17: Superhero or supervillain? J Immunol. 189(7):3285–3291.

McGreal E.P., Rosas M., Brown G.D., Zamze S., Wong S.Y.C., Gordon S., Martinez-Pomares L., and Taylor P.R. 2006. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology. 16(5):422–430.

Meager A., Visvalingam K., Peterson P., Möll K., Murumägi A., Krohn K., Eskelin P., Perheentupa J., Husebye E., Kadota Y., Willcox N., and Willcox N. 2006. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3(7):e289.

Michou L., Lasbleiz S., Rat A.-C., Migliorini P., Balsa A., Westhovens R., Barrera P., Alves H., Pierlot C., Glikmans E., Garnier S., Dausset J., Vaz C., Fernandes M., Petit-Teixeira E., Lemaire I., Pascual-Salcedo D., Bombardieri S., Dequeker J., Radstake T.R., Van Riel P., van de Putte L., Lopes-Vaz A., Prum B., Bardin T., Dieudé P., and Cornélis F., andEuropean Consortium on Rheumatoid Arthritis Families. 2007. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc. Natl. Acad. Sci. USA. 104(5):1649–1654.

Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K., Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., Kaneko H., Kondo N., Tsuge I., Yachie A., Sakiyama Y., Iwata T., Bessho F., Ohishi T., Joh K., Imai K., Kogawa K., Shinohara M., Fujieda M., Wakiguchi H., Pasic S., Abinun M., Ochs H.D., Renner E.D., Jansson A., Belohradsky B.H., Metin A., Shimizu N., Mizutani S., Miyawaki T., Nonoyama S., Karasuyama H., and Karasuyama H. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 25(5):745–755.

Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., and Karasuyama H. 2007. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 448(7157):1058–1062.

Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., Ito F., and Shimizu N. 1997. Positional cloning of the APECED gene. Nat. Genet. 17(4):393–398.

Nahum A., Bates A., Sharfe N., and Roifman C.M. 2008. Association of the lymphoid protein tyrosine phosphatase, R620W variant, with chronic mucocutaneous candidiasis. J. Allergy Clin. Immunol. 122(6):1220–1222.

Nahum A., Dadi H., Bates A., and Roifman C.M. 2011. The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity. J. Allergy Clin. Immunol. 127(2):528–531.

Nahum A., Dadi H., Bates A., and Roifman C.M. 2012. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun. Rev. 11(5):341–347.

Netea M.G., Gow N.A.R., Munro C.A., Bates S., Collins C., Ferwerda G., Hobson R.P., Bertram G., Hughes H.B., Jansen T., Jacobs L., Buurman E.T., Gijzen K., Williams D.L., Torensma R., McKinnon A., MacCallum D.M., Odds F.C., Van der Meer J.W., Brown A.J., and Kullberg B.J. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116(6): 1642–1650.

Okada S., Markle J.G., Deenick E.K., Mele F., Averbuch D., Lagos M., Alzahrani M., Al-Muhsen S., Halwani R., Ma C.S., Wong N., Soudais C., Henderson L.A., Marzouqa H., Shamma J., Gonzalez M., Martinez-Barricarte R., Okada C., Avery D.T., Latorre D., Deswarte C., Jabot-Hanin F., Torrado E., Fountain J., Belkadi A., Itan Y., Boisson B., Migaud M., Arlehamn C.S.L., Sette A., Breton S., McCluskey J., Rossjohn J., de Villartay J.P., Moshous D., Hambleton S., Latour S., Arkwright P.D., Picard C., Lantz O., Engelhard D., Kobayashi M., Abel L., Cooper A.M., Notarangelo L.D., Boisson-Dupuis S., Puel A., Sallusto F., Bustamante J., Tangye S.G., and Casanova J.L. 2015. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 349(6248):606–613.

Ortega M., Rovira M., Almela M., Marco F., de la Bellacasa J.P., Martínez J.A., Carreras E., and Mensa J. 2005. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann. Hematol. 84(1):40–46.

Ouederni M., Sanal O., Ikinciogullari A., Tezcan I., Dogu F., Sologuren I., Pedraza-Sánchez S., Keser M., Tanir G., Nieuwhof C., Colino E., Kumararatne D., Levy J., Kutukculer N., Aytekin C., Herrera-Ramos E., Bhatti M., Karaca N., Barbouche R., Broides A., Goudouris E., Franco J.L., Parvaneh N., Reisli I., Strickler A., Shcherbina A., Somer A., Segal A., Angel-Moreno A., Lezana-Fernandez J.L., Bejaoui M., Bobadilla-Del Valle M., Kachboura S., Sentongo T., Ben-Mustapha I., Bustamante J., Picard C., Puel A., Boisson-Dupuis S., Abel L., Casanova J.L., and Rodríguez-Gallego C. 2014. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin. Infect. Dis. 58(2):204–213.

Pedroza L.A., Kumar V., Sanborn K.B., Mace E.M., Niinikoski H., Nadeau K., Vasconcelos Dde M., Perez E., Jyonouchi S., Jyonouchi H., Banerjee P.P., Ruuskanen O., Condino-Neto A., and Orange J.S. 2012. Autoimmune regulator (AIRE) contributes to Dectin-1-induced TNF-α production and complexes with caspase recruitment domain-containing protein 9 (CARD9), spleen tyrosine kinase (Syk), and Dectin-1. J. Allergy Clin. Immunol. 129(2):464–472, 472.e1–472.e3.

Perheentupa J. 2006. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 91(8):2843–2850.

Plantinga T.S., Johnson M.D., Scott W.K., van de Vosse E., Velez Edwards D.R., Smith P.B., Alexander B.D., Yang J.C., Kremer D., Laird G.M., Oosting M., Joosten L.A., van der Meer J.W., van Dissel J.T., Walsh T.J., Perfect J.R., Kullberg B.J., and Netea M.G. 2012. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J. Infect. Dis. 205(6):934–943.

Plantinga T.S., van der Velden W.J.F.M., Ferwerda B., van Spriel A.B., Adema G., Feuth T., Donnelly J.P., Brown G.D., Kullberg B.J., Blijlevens N.M., and Netea M.G. 2009. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 49(5):724–732.

Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., Gumbleton M., Toulon A., Bodemer C., El-Baghdadi J., Whitters M., Paradis T., Brooks J., Collins M., Wolfman N.M., Al-Muhsen S., Galicchio M., Abel L., Picard C., and Casanova J.L. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 332(6025):65–68.

Puel A., Döffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachée-Chardin M., Toulon A., Bustamante J., Al-Muhsen S., Al-Owain M., Arkwright P.D., Costigan C., McConnell V., Cant A.J., Abinun M., Polak M., Bougnères P.F., Kumararatne D., Marodi L., Nahum A., Roifman C., Blanche S., Fischer A., Bodemer C., Abel L., Lilic D., and Casanova J.L. 2010. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207(2):291–297.

Robinson M.J., Osorio F., Rosas M., Freitas R.P., Schweighoffer E., Gross O., Verbeek J.S., Ruland J., Tybulewicz V., Brown G.D., Moita L.F., Taylor P.R., and Reis e Sousa C. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 206(9):2037–2051.

Rogers N.C., Slack E.C., Edwards A.D., Nolte M.A., Schulz O., Schweighoffer E., Williams D.L., Gordon S., Tybulewicz V.L., Brown G.D., and Reis e Sousa C. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 22(4):507–517.

Rosentul D.C., Plantinga T.S., Oosting M., Scott W.K., Velez Edwards D.R., Smith P.B., Alexander B.D., Yang J.C., Laird G.M., Joosten L.A., van der Meer J.W., Perfect J.R., Kullberg B.J., Netea M.G., and Johnson M.D. 2011. Genetic variation in the Dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J. Infect. Dis. 204(7):1138–1145.

Rutz S., Eidenschenk C., and Ouyang W. 2013. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252(1):116–132.

Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. 1997. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA. 94(7):3168–3171.

Sharfe N., Nahum A., Newell A., Dadi H., Ngan B., Pereira S.L., Herbrick J.A., and Roifman C.M. 2014. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1. J. Allergy. Clin. Immunoly. 133(3):807–817.

Smeekens S.P., Ng A., Kumar V., Johnson M.D., Plantinga T.S., van Diemen C., Arts P., Verwiel E.T., Gresnigt M.S., Fransen K., van Sommeren S., Oosting M., Cheng S.C., Joosten L.A., Hoischen A., Kullberg B.J., Scott W.K., Perfect J.R., van der Meer J.W., Wijmenga C., Netea M.G., and Xavier R.J. 2013a. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat. Commun. 4:1342.

Smeekens S.P., van de Veerdonk F.L., Kullberg B.J., and Netea M.G. 2013b. Genetic susceptibility to Candida infections. EMBO Mol. Med. 5(6):805–813.

Sobel J.D. 2007. Vulvovaginal candidosis. Lancet. 369(9577):1961–1971.

Uzel G., Sampaio E.P., Lawrence M.G., Hsu A.P., Hackett M., Dorsey M.J., Noel R.J., Verbsky J.W., Freeman A.F., Janssen E., Bonilla F.A., Pechacek J., Chandrasekaran P., Browne S.K., Agharahimi A., Gharib A.M., Mannurita S.C., Yim J.J., Gambineri E., Torgerson T., Tran D.Q., Milner J.D., and Holland S.M. 2013. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation–polyendocrinopathy–enteropathy–X-linked–like syndrome. J. Allergy Clin. Immunol. 131(6):1611–1623.

van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., Smits-van der Graaf C.A., Kullberg B.J., van der Meer J.W., Lilic D., Veltman J.A., and Netea M.G. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365(1):54–61.

Van der Graaf C.A.A., Netea M.G., Morré S.A., Den Heijer M., Verweij P.E., Van der Meer J.W.M., and Kullberg B.J. 2006. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw. 17(1):29–34.

Vang T., Congia M., Macis M.D., Musumeci L., Orrú V., Zavattari P., Nika K., Tautz L., Taskén K., Cucca F., Mustelin T., and Bottini N. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37(12):1317–1319.

Viscoli C., Girmenia C., Marinus A., Collette L., Martino P., Vandercam B., Doyen C., Lebeau B., Spence D., Krcmery V., De Pauw B., and Meunier F. 1999. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin. Infect. Dis. 28(5):1071–1079.

Woehrle T., Du W., Goetz A., Hsu H.-Y., Joos T.O., Weiss M., Bauer U., Brueckner U.B., and Marion Schneider E. 2008. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine. 41(3):322–329.

Wu H., Cantor R.M., Graham D.S.C., Lingren C.M., Farwell L., Jager P.L., Bottini N., Grossman J.M., Wallace D.J., Hahn B.H., Julkunen H., Hebert L.A., Rovin B.H., Birmingham D.J., Rioux J.D., Yu C.Y., Kere J., Vyse T.J., and Tsao B.P. 2005. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: Increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis. Rheum. 52(8):2396–2402.

Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., and Dong C. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282(13):9358–9363.

Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., Matthews H.F., Davis J., Turner M.L., Uzel G., Holland S.M., and Su H.C. 2009. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361(21):2046–2055.

Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., Monticelli S., and Lanzavecchia A Sallusto F. 2012. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature. 484(7395): 514–518.